4//SEC Filing
Sebree Terri B 4
Accession 0001062993-22-001778
CIK 0001621443other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 4:14 PM ET
Size
7.0 KB
Accession
0001062993-22-001778
Insider Transaction Report
Form 4
Sebree Terri B
President
Transactions
- Award
Common Stock
2022-01-26+85,000→ 346,146 total - Award
Stock Option (right to buy)
2022-01-26+125,000→ 125,000 totalExercise: $2.41Exp: 2032-01-26→ Common Stock (125,000 underlying)
Footnotes (2)
- [F1]The restricted stock award will fully vest on January 26, 2024, subject to continued employment with the Company through the applicable vesting date.
- [F2]The stock option vests 25% on the first anniversary of the date of the grant, with the remainder vesting in 12 equal quarterly installments thereafter, subject to continued employment with the Company through the applicable vesting date.
Issuer
Zynerba Pharmaceuticals, Inc.
CIK 0001621443
Entity typeother
Related Parties
1- filerCIK 0001297912
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 4:14 PM ET
- Size
- 7.0 KB